Las Vegas, NV


An Rx for Behavioral Health Equity—
Digital Therapeutics

  • March 01, 2022
  • 1:00 PM – 2:00 PM ET
  • Online

Health inequities and escalating mental health needs are increasingly evident through the ongoing COVID-19 pandemic and national turmoil. Some of the communities most affected by these public health crises are at the highest risk for not receiving mental health care. There are many reasons for this disconnect, including lack of available providers, long wait times, personal obstacles to attending appointments, and financial concerns.

Digital therapeutic treatments can — and do — play a role in bridging gaps in behavioral health. They transcend care access limitations due to geography, socioeconomic status, trust of traditional institutions and more. They also provide a much-needed treatment alternative when typical medications and therapy are not effective for an individual patient.

As these new treatment options increasingly move to the front lines of behavioral care and into patients’ homes, the stakes have never been higher in ensuring they are proven, cost effective and simple to use. They also must fit into existing health insurance provider care plans to support seamless implementation. With so many digital therapeutics being introduced across the spectrum of healthcare needs, how can you assess what really delivers improved outcomes and lower costs?

Emerging treatments in behavioral health allow individuals to access care solutions when, where and how works best for them. But health insurance providers also seek to understand when it makes sense to incorporate these new treatments. This webinar delves into five key criteria for both identifying and evaluating high-quality, clinically proven digital therapeutic solutions.

Digital therapeutics expand treatment possibilities for complex behavioral health conditions. For example, 98% of panic disorder patients have at least one behavioral health comorbidity such as major depressive disorder, anxiety disorder or alcohol use disorders (Virpi, 2012). Comorbid conditions increase costs and call for targeted treatments.

An expert panel will discuss real-world experiences around using digital therapeutics for behavioral health—the challenges, the successes and key learnings for the future.

Attendees will learn about:

  • The 5 criteria to apply when evaluating digital therapeutics
  • How digital therapeutics lower barriers to care, improving access
  • The complementary role of digital therapeutics in current behavioral health offerings
  • Real-world examples of a digital therapeutic successfully treating complex, costly and growing mental health conditions
  • Best practices for measuring clinical and financial outcomes


Robert Cuyler, PhD
Chief Clinical Officer

Robert N. Cuyler, PhD, has been active in behavioral health telemedicine for more than 15 years. Prior to joining Freespira, Dr. Cuyler served as Chief Executive Officer of JSA Health Telepsychiatry, and as a Clinical Advisor to MDLive/Breakthrough Behavioral and BrainCheck. His broad telemedicine-related experience includes implementation, reimbursement policy, practitioner training, technology selection, and business development. He is an author and presenter on telemedicine and technological innovations in behavioral health. Dr. Cuyler is also the President of Clinical Psychology Consultants, LLP, his Houston practice.

Dr. Avrim Fishkind
Chief Clinical Officer, Orbis Health
Director of Telepsychiatry, The Harris Center
Freespira Medical Director, Psychiatry

Dr. Avrim Fishkind has practiced emergency and community psychiatry for the last 25 years. He is a past president of the American Association for Emergency Psychiatry. In 2007, he founded JSA Health Telepsychiatry, one of the nation’s first 24/7 telepsychiatry companies. Dr. Fishkind frequently speaks at American Psychiatric Association conferences on various topics including digital futures for psychiatrists involving telemedicine and prescription digital therapeutics. Currently, he serves as a Medical Director-Psychiatry, at Freespira, and Director of Telepsychiatry at The Harris Center, Houston, the country’s third-largest community mental health center. At Orbis Health, he explores artificial intelligence and machine learning applications for mental health.

Solome Tibebu
Founder & Host, Going Digital: Behavioral Health Tech
Freespira Consultant

Solome Tibebu is passionate about technologies and solutions transforming mental health, equity and access. As a behavioral health technology expert, she works with a wide range of organizations including telehealth and mental health companies, pharma, and health plans and systems. She is the founding Fund Director for The Upswing Fund for Adolescent Mental Health, a fund seeded by Melinda French Gates’ Pivotal Ventures. She is also founder and host of “Going Digital: Behavioral Health Tech” – the largest conference on expanding access to mental health and substance use services through technology and innovation.

Miranda Wilson
Senior Director, Patient Engagement and Experience

Miranda Wilson focuses on the needs of individuals who may benefit from Freespira’s breakthrough treatment for panic disorder and PTSD symptoms. Before joining Freespira, she worked within the cross-functional Center of Excellence at Blue Cross Blue Shield of Minnesota as leader of the member engagement team. Miranda brings more than 15 years of experience in multi-channel and omni-channel engagement strategy, experience design, content strategy, multimedia production, and product development